Energy Recovery Announces New Stock Repurchase Program

Energy Recovery, Inc. (ERII) announced on March 8 that the company’s Board of Directors authorized a new stock repurchase program. Under this new program, the company can repurchase up to $10 million worth of outstanding shares. Energy Recovery provides energy solutions to worldwide industrial fluid flow markets.   Sonal received the news and alerted subscribers […]

Read more...

Scientific Games Awarded New Contract From Arizona Lottery

Scientific Games Corporation (SGMS) announced on March 7 that the company received a new contract from the Arizona Lottery. The contract will last for five years, and Scientific Games will provide administrative systems technology for the Arizona Lottery’s headquarters in Phoenix. The new administrative systems will be integrated with the advanced gaming and retail technology […]

Read more...

Travelzoo Board of Directors Authorizes Share Repurchase Program

Travelzoo (TZOO) announced on March 5 that the company’s Board of Directors authorized a new share repurchase program. Under the terms of the agreement, Travelzoo can repurchase up to 500,000 shares of outstanding common stock. Travelzoo is a global publisher of exclusive travel and entertainment offers for its members.   Sonal detected the even and […]

Read more...

Comtech Receives $123.6 Million Contract from U.S. Army

On March 5, Comtech Telecommunications Corp. (CMTL) announced that its Command and Control Technologies group received a three-year contract from the U.S. Army worth $123.6 million. Under the contract, Comtech will provide ongoing sustainment services for the AN/TSC-198A SNAP (Secret and Non-classified Internet Protocol Router Access Point), Very Small Aperture Terminals. SNAP terminals provide quick, […]

Read more...

G1 Therapeutics Reports Positive Clinical Trial Results in Patients Receiving Chemotherapy for Small Cell Lung Cancer

On March 5, G1 Therapeutics, Inc. (GTHX) reported positive topline data from its Phase 2a trial for Trilaciclib in patients receiving chemotherapy for first-line small cell lung cancer. The data from the trial showed clear evidence that Trilaciclib preserved bone marrow and immune system function from damage due to chemotherapy treatment. Trilaciclib would be the […]

Read more...

CPI Antenna Systems Division to Buy Antenna Division of Viasat

On March 12, Communications and Power Industries LLC (CPI) announced that its Antenna Systems Division signed an agreement to purchase the limited-motion satellite antenna division of Viasat, Inc. (VSAT). By selling its antenna systems division, Viasat will be able to focus more on its core business of antenna and communications technologies for broadband markets. The […]

Read more...

FDA Accepts Jazz Pharmaceuticals’ NDA for Solriamfetol Treatment in Patients with Narcolepsy and Sleep Apnea

On March 2, Jazz Pharmaceuticals plc (JAZZ) announced that the FDA has accepted the company’s filing of a New Drug Application (NDA) with standard review for market approval of Solriamfetol. The drug is an investigational medicine used for the treatment of excessive sleepiness in patients with narcolepsy and obstructive sleep apnea (OSA). The company hopes […]

Read more...